BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 12941425)

  • 1. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer.
    Kotacková L; Baláziová E; Sedo A
    Folia Biol (Praha); 2009; 55(3):77-84. PubMed ID: 19545486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
    Park J; Ajami K; Yu DM; Gorrell MD
    Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Zhang H; Chen Y; Keane FM; Gorrell MD
    Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function in dipeptidyl peptidase IV and related proteins.
    Gorrell MD; Wang XM; Park J; Ajami K; Yu DM; Knott H; Seth D; McCaughan GW
    Adv Exp Med Biol; 2006; 575():45-54. PubMed ID: 16700507
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
    Van der Veken P; Haemers A; Augustyns K
    Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
    Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
    World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.
    Tang HK; Chen KC; Liou GG; Cheng SC; Chien CH; Tang HY; Huang LH; Chang HP; Chou CY; Chen X
    FEBS Lett; 2011 Nov; 585(21):3409-14. PubMed ID: 22001206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
    Chen SJ; Jiaang WT
    Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prolyl oligopeptidase family.
    Polgár L
    Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
    Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
    Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
    J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline specific endo- and exopeptidases.
    Walter R; Simmons WH; Yoshimoto T
    Mol Cell Biochem; 1980 Apr; 30(2):111-27. PubMed ID: 6991912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
    Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
    J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
    Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
    J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
    Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
    FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein.
    Tsai TY; Yeh TK; Chen X; Hsu T; Jao YC; Huang CH; Song JS; Huang YC; Chien CH; Chiu JH; Yen SC; Tang HK; Chao YS; Jiaang WT
    J Med Chem; 2010 Sep; 53(18):6572-83. PubMed ID: 20718420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.
    Qi SY; Riviere PJ; Trojnar J; Junien JL; Akinsanya KO
    Biochem J; 2003 Jul; 373(Pt 1):179-89. PubMed ID: 12662155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.